Cargando…

Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model

SIMPLE SUMMARY: A diagnosis of glioblastoma carries a uniformly dismal prognosis. Contributing to this is the near certain chance of aggressive tumor spread and recurrence following treatment. Tumor cell motility may provide one way to characterize the tendencies of glioblastomas to spread and recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulford, Kellen, McMahon, Mariah, Gardeck, Andrew M., Hunt, Matthew A., Chen, Clark C., Odde, David J., Wilke, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833801/
https://www.ncbi.nlm.nih.gov/pubmed/35158845
http://dx.doi.org/10.3390/cancers14030578
_version_ 1784649033292185600
author Mulford, Kellen
McMahon, Mariah
Gardeck, Andrew M.
Hunt, Matthew A.
Chen, Clark C.
Odde, David J.
Wilke, Christopher
author_facet Mulford, Kellen
McMahon, Mariah
Gardeck, Andrew M.
Hunt, Matthew A.
Chen, Clark C.
Odde, David J.
Wilke, Christopher
author_sort Mulford, Kellen
collection PubMed
description SIMPLE SUMMARY: A diagnosis of glioblastoma carries a uniformly dismal prognosis. Contributing to this is the near certain chance of aggressive tumor spread and recurrence following treatment. Tumor cell motility may provide one way to characterize the tendencies of glioblastomas to spread and recur. We sought to develop a non-invasive technique for assessing tumor cell motility using quantitative features derived from in vivo preoperative magnetic resonance imaging. Our regression model accurately predicted tumor cell motility in a cohort of participants with preoperative imaging who also had mean cellular motility calculated for their resected tumor cells from time-lapse videos. This work establishes the feasibility of non-invasively characterizing the kinetic properties of tumors and could be used to select patients for motility-targeting precision therapies. ABSTRACT: Characterizing the motile properties of glioblastoma tumor cells could provide a useful way to predict the spread of tumors and to tailor the therapeutic approach. Radiomics has emerged as a diagnostic tool in the classification of tumor grade, stage, and prognosis. The purpose of this work is to examine the potential of radiomics to predict the motility of glioblastoma cells. Tissue specimens were obtained from 31 patients undergoing surgical resection of glioblastoma. Mean tumor cell motility was calculated from time-lapse videos of specimen cells. Manual segmentation was used to define the border of the enhancing tumor T1-weighted MR images, and 107 radiomics features were extracted from the normalized image volumes. Model parameter coefficients were estimated using the adaptive lasso technique validated with leave-one-out cross validation (LOOCV) and permutation tests. The R-squared value for the predictive model was 0.60 with p-values for each individual parameter estimate less than 0.0001. Permutation test models trained with scrambled motility failed to produce a model that out-performed the model trained on the true data. The results of this work suggest that it is possible for a quantitative MRI feature-based regression model to non-invasively predict the cellular motility of glioblastomas.
format Online
Article
Text
id pubmed-8833801
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88338012022-02-12 Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model Mulford, Kellen McMahon, Mariah Gardeck, Andrew M. Hunt, Matthew A. Chen, Clark C. Odde, David J. Wilke, Christopher Cancers (Basel) Article SIMPLE SUMMARY: A diagnosis of glioblastoma carries a uniformly dismal prognosis. Contributing to this is the near certain chance of aggressive tumor spread and recurrence following treatment. Tumor cell motility may provide one way to characterize the tendencies of glioblastomas to spread and recur. We sought to develop a non-invasive technique for assessing tumor cell motility using quantitative features derived from in vivo preoperative magnetic resonance imaging. Our regression model accurately predicted tumor cell motility in a cohort of participants with preoperative imaging who also had mean cellular motility calculated for their resected tumor cells from time-lapse videos. This work establishes the feasibility of non-invasively characterizing the kinetic properties of tumors and could be used to select patients for motility-targeting precision therapies. ABSTRACT: Characterizing the motile properties of glioblastoma tumor cells could provide a useful way to predict the spread of tumors and to tailor the therapeutic approach. Radiomics has emerged as a diagnostic tool in the classification of tumor grade, stage, and prognosis. The purpose of this work is to examine the potential of radiomics to predict the motility of glioblastoma cells. Tissue specimens were obtained from 31 patients undergoing surgical resection of glioblastoma. Mean tumor cell motility was calculated from time-lapse videos of specimen cells. Manual segmentation was used to define the border of the enhancing tumor T1-weighted MR images, and 107 radiomics features were extracted from the normalized image volumes. Model parameter coefficients were estimated using the adaptive lasso technique validated with leave-one-out cross validation (LOOCV) and permutation tests. The R-squared value for the predictive model was 0.60 with p-values for each individual parameter estimate less than 0.0001. Permutation test models trained with scrambled motility failed to produce a model that out-performed the model trained on the true data. The results of this work suggest that it is possible for a quantitative MRI feature-based regression model to non-invasively predict the cellular motility of glioblastomas. MDPI 2022-01-24 /pmc/articles/PMC8833801/ /pubmed/35158845 http://dx.doi.org/10.3390/cancers14030578 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mulford, Kellen
McMahon, Mariah
Gardeck, Andrew M.
Hunt, Matthew A.
Chen, Clark C.
Odde, David J.
Wilke, Christopher
Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model
title Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model
title_full Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model
title_fullStr Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model
title_full_unstemmed Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model
title_short Predicting Glioblastoma Cellular Motility from In Vivo MRI with a Radiomics Based Regression Model
title_sort predicting glioblastoma cellular motility from in vivo mri with a radiomics based regression model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833801/
https://www.ncbi.nlm.nih.gov/pubmed/35158845
http://dx.doi.org/10.3390/cancers14030578
work_keys_str_mv AT mulfordkellen predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel
AT mcmahonmariah predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel
AT gardeckandrewm predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel
AT huntmatthewa predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel
AT chenclarkc predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel
AT oddedavidj predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel
AT wilkechristopher predictingglioblastomacellularmotilityfrominvivomriwitharadiomicsbasedregressionmodel